How to Protect the Vulnerable Groups in Drug Clinical Trials
10.12026/j.issn.1001-8565.2017.05.12
- VernacularTitle:论如何在药物临床试验中保护弱势群体
- Author:
Xin LIN
;
Xin ZHOU
- Keywords:
Drug Clinical Trial;
Vulnerable Groups;
Ethics Committee;
The Subjects
- From:
Chinese Medical Ethics
2017;30(5):572-575
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To find a better way to protect the security and interests of vulnerable groups by exploring the problem of protecting the vulnerable groups in drug clinical trial from the perspectives of ethics committees,organization and researchers.Methods:According to the relevant literature and the actual situation of the hospital,this paper analyzed the security issues of vulnerable groups comprehensively.Results:Only the ethics committees,organization and researchers work together,can it protect the security and interests of vulnerable groups to the greatest extents.Conclusion:Further research on the security of vulnerable groups not only promotes the development of human health,but also plays a decisive role in improving the protection of subjects in drug clinical trial.